NCT02593201View on ClinicalTrials.gov

The Efficacy of Prolonged Antibiotic Therapy for the Prevention of Relapsing Peritonitis in Peritoneal Dialysis Patients With High Dialysis Effluent Bacterial DNA Fragment Levels

PHASE4CompletedINTERVENTIONAL
Enrollment

358

Participants

Timeline

Start Date

February 26, 2016

Primary Completion Date

December 31, 2018

Study Completion Date

June 30, 2019

Conditions
Peritoneal Dialysis
Interventions
DRUG

Extended antibiotics (cefazolin or ceftazidime)

To continue with the existing effective antibiotic therapy for one extra week

DRUG

Usual antibiotics (cefazolin or ceftazidime)

Usual duration of effective antibiotic therapy therapy

Trial Locations (1)

Unknown

Department of Medicine & Therapeutics, Prince of Wales Hospital, Shatin

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER

NCT02593201 - The Efficacy of Prolonged Antibiotic Therapy for the Prevention of Relapsing Peritonitis in Peritoneal Dialysis Patients With High Dialysis Effluent Bacterial DNA Fragment Levels | Biotech Hunter | Biotech Hunter